🌱 KidneyEnergy.com

← brief for 2026-11-12 · Slowing decline

Ketohexokinase, the principal fructose-metabolising enzyme is downregulated in the kidneys of rodents and humans with chronic kidney disease

Article D Peer reviewed Preclinical

Key takeaways

This study looked at a specific enzyme in the kidneys of animals and people with chronic kidney disease. It found that this enzyme is less active in diseased kidneys. This was done in animals and cells, not in a human trial yet.

Who did this work

David Chacha Mathew (University College London) · Siavash Beikoghli Kalkhoran (University College London) · Alan David Salama (The Royal Free Hospital) · Sean M. Davidson (University College London) · Derek M. Yellon (University College London)

Source

Article · OpenAlex, CKD works · 2026-11-11
https://doi.org/10.3389/fneph.2026.1789437